Yes, immunotherapy for glioblastoma is being actively developed in Germany. For example, personalized peptide vaccines based on neoantigens and dendritic cell vaccines are showing promise in clinical trials and research.
glioblastoma vaccine germany This offers hope for many patients to prolong their lives.